Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy
Open Access
Abstract
One of the most relevant pathophysiological hallmarks of β-thalassemia is the accumulation of toxic α-globin chains inside erythroid cells, which is responsible for their premature death (hemolysis). In this context, the availability of an experimental model system mimicking the excess in α-globin chain production is still lacking. The objective of the present study was to produce and characterize K562 cellular clones forced to produce high amounts of α-globin, in order to develop an experimental model system suitable for studies aimed at the reduction of the accumulation of toxic α-globin aggregates. In the present study, we produced and characterized K562 cellular clones that, unlike the original K562 cell line, stably produced high levels of α-globin protein. As expected, the obtained clones had a tendency to undergo apoptosis that was proportional to the accumulation of α-globin, confirming the pivotal role of α-globin accumulation in damaging erythroid cells. Interestingly, the obtained clones seemed to trigger autophagy spontaneously, probably to overcome the accumulation/toxicity of the α-globin. We propose this new model system for the screening of pharmacological agents able to activate the full program of autophagy to reduce α-globin accumulation, but the model may be also suitable for new therapeutical approaches targeted at the reduction of the expression of the α-globin gene.Keywords
Funding Information
- Wellcome Trust (208872/Z/17/Z, AIFA-2016-02364887, 306201-FP7-HEALTH-2012-INNOVATION-1)
- Agenzia Italiana del Farmaco, Ministero della Salute (208872/Z/17/Z, AIFA-2016-02364887, 306201-FP7-HEALTH-2012-INNOVATION-1)
- EU THALAMOSS Project (208872/Z/17/Z, AIFA-2016-02364887, 306201-FP7-HEALTH-2012-INNOVATION-1)
- FIR and FAR funds from the University of Ferrara (208872/Z/17/Z, AIFA-2016-02364887, 306201-FP7-HEALTH-2012-INNOVATION-1)
- Interuniversity Consortium for Biotechnology (CIB) (208872/Z/17/Z, AIFA-2016-02364887, 306201-FP7-HEALTH-2012-INNOVATION-1)
This publication has 42 references indexed in Scilit:
- Emodin can induce K562 cells to erythroid differentiation and improve the expression of globin genesMolecular and Cellular Biochemistry, 2013
- Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood CellsPLOS ONE, 2013
- Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemiaBlood, 2012
- Beta-thalassemiaOrphanet Journal of Rare Diseases, 2010
- siRNA-mediated reduction of -globin results in phenotypic improvements in -thalassemic cellsHaematologica, 2008
- Restoration of the balanced α/β-globin gene expression in β 654 -thalassemia mice using combined RNAi and antisense RNA approachHuman Molecular Genetics, 2007
- Induction of fetal haemoglobin expression in erythroid cells – A model based on iron availability signallingMedical Hypotheses, 2005
- Inhibition of Expression of a Mouse .ALPHA.-Globin Gene by Plasmids that Include Antisense Oligonucleotides.Cell Structure and Function, 1992
- Electrophoretic separation of human embryonic globin demonstrates “α-thalassemia” in human leukemia cell line K562Biochemical and Biophysical Research Communications, 1980
- Imbalance in α and β Globin Synthesis Associated with a HemoglobinopathyJournal of Clinical Investigation, 1974